Interaction Risk: Green Tea Consumption in Patients Taking Alprazolam
- PMID: 40296492
- DOI: 10.2174/0118723128366248250206081121
Interaction Risk: Green Tea Consumption in Patients Taking Alprazolam
Abstract
developing area of clinical interest is the potential interactions between drugs and herbal products. The potential risk of an interaction between green tea (Camellia sinensis) and alprazolam, a benzodiazepine that is commonly recommended for anxiety disorders, is discussed in this review. Numerous bioactive components included in green tea, such as caffeine and catechins, may alter the pharmacokinetics of alprazolam by altering its metabolism, excretion, or absorption. It has been shown that green tea affects the activity of cytochrome P450 enzymes, particularly CYP3A4, which is involved in alprazolam metabolism. Green tea may increase alprazolam plasma levels and increase the likelihood of adverse effects, such as drowsiness or motor incoordination due to CYP3A4 inhibition, which will be studied from the existing literature and pharmacological evidence. While definitive clinical trials are limited, the aim of the review is to emphasize the necessity for increased awareness among healthcare practitioners and patients regarding potential drug-herb interactions, especially in individuals utilizing anxiolytic drugs along with green tea consumption. Additional clinical investigations are necessary to formulate solid guidelines for the safe consumption of green tea by those using alprazolam.
Keywords: Alprazolam; anxiolytic drugs.; cytochrome P450; drug-herb interactions; green tea; pharmacokinetics.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers.Drug Metab Dispos. 2004 Sep;32(9):906-8. doi: 10.1124/dmd.104.000083. Drug Metab Dispos. 2004. PMID: 15319329
-
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).Planta Med. 2017 Apr;83(6):496-508. doi: 10.1055/s-0043-100934. Epub 2017 Jan 24. Planta Med. 2017. PMID: 28118673 Review.
-
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.Eur J Clin Pharmacol. 2012 May;68(5):571-7. doi: 10.1007/s00228-011-1163-8. Epub 2011 Dec 9. Eur J Clin Pharmacol. 2012. PMID: 22159869
-
Green Tea Catechins as Perpetrators of Drug Pharmacokinetic Interactions.Clin Pharmacol Ther. 2025 Jul;118(1):45-61. doi: 10.1002/cpt.3547. Epub 2025 Jan 2. Clin Pharmacol Ther. 2025. PMID: 39748104 Review.
-
Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.Clin Pharmacol Ther. 2003 Dec;74(6):536-42. doi: 10.1016/j.clpt.2003.08.010. Clin Pharmacol Ther. 2003. PMID: 14663456 Clinical Trial.